Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Environment, development and sustainability ; : 2024/01/01 00:00:00.000, 2023.
Article in English | EuropePMC | ID: covidwho-2290066

ABSTRACT

Since 2019n-CoV has swept the whole world, people's daily life is affected seriously and the public space system is facing to major challenges. Community public space should be re-evaluated and optimized as people change the way they use it. This research conducted a nationwide questionnaire survey in China, which collected the opinions of residents on community public space from the perspective of epidemic prevention and social needs to select research indicators. The questionnaire data were processed through the frequency analysis method, precedence chart and TOPSIS. We found: (1) under the background of the epidemic, people pay more attention to the satisfaction of leisure activities in community public space and the control of social spacing during activities;(2) the current assessment result of community public space risk of 2019-nCoV exposure is 0.386, which is relatively high;and (3) the exposure risk of the community can be effectively reduced by controlling for the two indicators of social distance and social facility sterilization. When the social distance is 1.8–3 m and the facility sterilization is once a day, the community public space minimizes exposure risk. In view of the above results, this paper selects the Wuhan start-up area of Wuhan, China, as an example for carrying out the optimization design of community public space based on the epidemic and the design the space optimization model for the two indicators of social distance and facility disinfection from both software and hardware aspects.

2.
Front Public Health ; 11: 1073552, 2023.
Article in English | MEDLINE | ID: covidwho-2288935

ABSTRACT

Background: China has been increasing the investment in Primary Health Care Institutions (PHCIs) since the launch of the New Health Care System Reform in 2009. It is a crucial concern whether the PHCIs can meet residents' need both in urban and rural with the limited government finance, especially encountering the challenge of the COVID-19. This study aimed to reveal the trend of the primary health service efficiency in the past decade, compare the urban-rural differences, and explore relevant factors. Methods: DEA and Malmquist models were applied to calculate the health service efficiency of PHCIs among 28 provinces in China, with the input variables including the number of institutions, number of beds, number of health technicians, and the outputs variables including the number of outpatients and emergency visits, number of discharged patients. And the Tobit model was used to analyze the factors on the efficiency in urban and rural. A sensitivity analysis for model validations was also carried out. Results: The average technical efficiency (TE) of urban PHCIs fluctuated from 63.3% to 67.1%, which was lower than that in rural (75.8-82.2%) from 2009 to 2019. In terms of dynamic efficiency, the urban PHCIs performed better than the rural, and the trends in the total factor productivity change were associated with favorable technology advancement. The population density and dependency ratio were the key factors on TE in both of the urban and rural PHCIs, and these two factors were positively correlated to TE. In terms of TE, it was negatively correlated with the proportion of total health expenditure as a percentage of GDP in urban PHCIs, while in rural it was positively correlated with the urbanization rate and negatively correlated with GDP per capita. Besides, the tests of Mann-Whitney U, and Kruskal-Wallis H indicated the internal validity and robustness of the chosen DEA and Malmquist models. Conclusions: It needs to reduce the health resource wastes and increase service provision in urban PHCIs. Meanwhile, it is necessary to strengthen medical technology and gaining greater efficiency in rural PHCIs by technology renovation.


Subject(s)
Efficiency, Organizational , Primary Health Care , Humans , Primary Health Care/organization & administration , China
3.
Environ Dev Sustain ; : 1-24, 2023 Mar 14.
Article in English | MEDLINE | ID: covidwho-2287063

ABSTRACT

Since 2019n-CoV has swept the whole world, people's daily life is affected seriously and the public space system is facing to major challenges. Community public space should be re-evaluated and optimized as people change the way they use it. This research conducted a nationwide questionnaire survey in China, which collected the opinions of residents on community public space from the perspective of epidemic prevention and social needs to select research indicators. The questionnaire data were processed through the frequency analysis method, precedence chart and TOPSIS. We found: (1) under the background of the epidemic, people pay more attention to the satisfaction of leisure activities in community public space and the control of social spacing during activities; (2) the current assessment result of community public space risk of 2019-nCoV exposure is 0.386, which is relatively high; and (3) the exposure risk of the community can be effectively reduced by controlling for the two indicators of social distance and social facility sterilization. When the social distance is 1.8-3 m and the facility sterilization is once a day, the community public space minimizes exposure risk. In view of the above results, this paper selects the Wuhan start-up area of Wuhan, China, as an example for carrying out the optimization design of community public space based on the epidemic and the design the space optimization model for the two indicators of social distance and facility disinfection from both software and hardware aspects.

4.
iScience ; 25(5): 104309, 2022 May 20.
Article in English | MEDLINE | ID: covidwho-1804380

ABSTRACT

MicroRNAs (miRNAs) have been shown to play important roles in viral infections, but their associations with SARS-CoV-2 infection remain poorly understood. Here, we detected 85 differentially expressed miRNAs (DE-miRNAs) from 2,336 known and 361 novel miRNAs that were identified in 233 plasma samples from 61 healthy controls and 116 patients with COVID-19 using the high-throughput sequencing and computational analysis. These DE-miRNAs were associated with SASR-CoV-2 infection, disease severity, and viral persistence in the patients with COVID-19, respectively. Gene ontology and KEGG pathway analyses of the DE-miRNAs revealed their connections to viral infections, immune responses, and lung diseases. Finally, we established a machine learning model using the DE-miRNAs between various groups for classification of COVID-19 cases with different clinical presentations. Our findings may help understand the contribution of miRNAs to the pathogenesis of COVID-19 and identify potential biomarkers and molecular targets for diagnosis and treatment of SARS-CoV-2 infection.

6.
Sci Total Environ ; 748: 141560, 2020 Dec 15.
Article in English | MEDLINE | ID: covidwho-696105

ABSTRACT

The outbreak of the novel coronavirus disease (COVID-19) severely threatens the public health worldwide, but the transmission mechanism and the effectiveness of mitigation measures remain uncertain. Here we assess the role of airborne transmission in spreading the disease and the effectiveness of face covering in preventing inter-human transmission for the top-fifteen infected U.S. states during March 1 and May 18, 2020. For all fifteen states, the curve of total confirmed infections exhibits an initial sub-exponential growth and a subsequent linear growth after implementing social distancing/stay-at-home orders. The linearity extends one to two months for the six states without mandated face covering and to the onset of mandated face covering for the other nine states with this measure, reflecting a dynamic equilibrium between first-order transmission kinetics and intervention. For the states with mandated face covering, significant deviation from this linearity and curve flattening occur after the onset of this measure for seven states, with exceptions for two states. Most states exhibit persistent upward trends in the daily new infections after social distancing/stay-at-home orders, while reversed downward or slowing trends occur for eight states after implementing mandated face covering. The inadequacy of social distancing and stay-at-home measures alone in preventing inter-human transmission is reflected by the continuous linear growth in the total infection curve after implementing these measures, which is mainly driven by airborne transmission. We estimate that the number of the total infections prevented by face covering reaches ~252,000 on May 18 in seven states, which is equivalent to ~17% of the total infections in the nation. We conclude that airborne transmission and face covering play the dominant role in spreading the disease and flattening the total infection curve, respectively. Our findings provide policymakers and the public with compelling evidence that universal face covering, in conjunction with social distancing and hand hygiene, represents the maximal protection against inter-human transmission and the combination of these intervention measures with rapid and extensive testing as well as contact tracing is crucial in containing the COVID-19 pandemic.


Subject(s)
Betacoronavirus , Coronavirus Infections , Coronavirus , Pandemics , Pneumonia, Viral , COVID-19 , Humans , SARS-CoV-2 , United States/epidemiology
7.
Clin Infect Dis ; 72(4): 652-660, 2021 02 16.
Article in English | MEDLINE | ID: covidwho-638980

ABSTRACT

BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) has spread worldwide and continues to threaten peoples' health as well as put pressure on the accessibility of medical systems. Early prediction of survival of hospitalized patients will help in the clinical management of COVID-19, but a prediction model that is reliable and valid is still lacking. METHODS: We retrospectively enrolled 628 confirmed cases of COVID-19 using positive RT-PCR tests for SARS-CoV-2 in Tongji Hospital, Wuhan, China. These patients were randomly grouped into a training (60%) and a validation (40%) cohort. In the training cohort, LASSO regression analysis and multivariate Cox regression analysis were utilized to identify prognostic factors for in-hospital survival of patients with COVID-19. A nomogram based on the 3 variables was built for clinical use. AUCs, concordance indexes (C-index), and calibration curves were used to evaluate the efficiency of the nomogram in both training and validation cohorts. RESULTS: Hypertension, higher neutrophil-to-lymphocyte ratio, and increased NT-proBNP values were found to be significantly associated with poorer prognosis in hospitalized patients with COVID-19. The 3 predictors were further used to build a prediction nomogram. The C-indexes of the nomogram in the training and validation cohorts were 0.901 and 0.892, respectively. The AUC in the training cohort was 0.922 for 14-day and 0.919 for 21-day probability of in-hospital survival, while in the validation cohort this was 0.922 and 0.881, respectively. Moreover, the calibration curve for 14- and 21-day survival also showed high coherence between the predicted and actual probability of survival. CONCLUSIONS: We built a predictive model and constructed a nomogram for predicting in-hospital survival of patients with COVID-19. This model has good performance and might be utilized clinically in management of COVID-19.


Subject(s)
COVID-19 , Nomograms , China/epidemiology , Humans , Prognosis , Retrospective Studies , SARS-CoV-2
8.
Pathog Dis ; 78(3)2020 04 01.
Article in English | MEDLINE | ID: covidwho-616784

ABSTRACT

The coronavirus disease 2019 (COVID-2019) that emerged in Wuhan, China, has rapidly spread to many countries across all six WHO regions. However, its pathobiology remains incompletely understood and many efforts are underway to study it worldwide. To clarify its pathogenesis to some extent, it will inevitably require lots of COVID-2019-associated pathological autopsies. Pathologists from all over the world have raised concerns with pathological autopsy relating to COVID-2019. The issue of whether a person died from COVID-2019 infection or not is always an ambiguous problem in some cases, and ongoing epidemiology from China may shed light on it. This review retrospectively summarizes the research status of pathological autopsy for COVID-2019 deaths in China, which will be important for the cause of death, prevention, control and clinical strategies of COVID-2019. Moreover, it points out several challenges at autopsy. We believe pathological studies from China enable to correlate clinical symptoms and pathological features of COVID-2019 for doctors and provide an insight into COVID-2019 disease.


Subject(s)
Autopsy , Coronavirus Infections/pathology , Pneumonia, Viral/pathology , Betacoronavirus , COVID-19 , Cause of Death , China , Coronavirus Infections/mortality , Humans , Pandemics , Pneumonia, Viral/mortality , SARS-CoV-2
9.
Trends Pharmacol Sci ; 41(8): 531-543, 2020 08.
Article in English | MEDLINE | ID: covidwho-600931

ABSTRACT

Recent advances in the pathophysiologic understanding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has indicated that patients with severe coronavirus disease 2019 (COVID-19) might experience cytokine release syndrome (CRS), characterized by increased interleukin (IL)-6, IL-2, IL-7, IL-10, etc. Therefore, the treatment of cytokine storm has been proposed as a critical part of rescuing severe COVID-19. Several of the cytokines involved in COVID-19 employ a distinct intracellular signaling pathway mediated by Janus kinases (JAKs). JAK inhibition, therefore, presents an attractive therapeutic strategy for CRS, which is a common cause of adverse clinical outcomes in COVID-19. Below, we review the possibilities and challenges of targeting the pathway in COVID-19.


Subject(s)
Betacoronavirus/isolation & purification , Coronavirus Infections/physiopathology , Cytokine Release Syndrome/virology , Pneumonia, Viral/physiopathology , Animals , COVID-19 , Coronavirus Infections/drug therapy , Coronavirus Infections/immunology , Cytokine Release Syndrome/drug therapy , Cytokine Release Syndrome/immunology , Cytokines/immunology , Humans , Janus Kinases/metabolism , Pandemics , Pneumonia, Viral/drug therapy , Pneumonia, Viral/immunology , SARS-CoV-2 , STAT Transcription Factors/metabolism , Signal Transduction/physiology
10.
Proc Natl Acad Sci U S A ; 117(26): 14857-14863, 2020 06 30.
Article in English | MEDLINE | ID: covidwho-595563

ABSTRACT

Various mitigation measures have been implemented to fight the coronavirus disease 2019 (COVID-19) pandemic, including widely adopted social distancing and mandated face covering. However, assessing the effectiveness of those intervention practices hinges on the understanding of virus transmission, which remains uncertain. Here we show that airborne transmission is highly virulent and represents the dominant route to spread the disease. By analyzing the trend and mitigation measures in Wuhan, China, Italy, and New York City, from January 23 to May 9, 2020, we illustrate that the impacts of mitigation measures are discernable from the trends of the pandemic. Our analysis reveals that the difference with and without mandated face covering represents the determinant in shaping the pandemic trends in the three epicenters. This protective measure alone significantly reduced the number of infections, that is, by over 78,000 in Italy from April 6 to May 9 and over 66,000 in New York City from April 17 to May 9. Other mitigation measures, such as social distancing implemented in the United States, are insufficient by themselves in protecting the public. We conclude that wearing of face masks in public corresponds to the most effective means to prevent interhuman transmission, and this inexpensive practice, in conjunction with simultaneous social distancing, quarantine, and contact tracing, represents the most likely fighting opportunity to stop the COVID-19 pandemic. Our work also highlights the fact that sound science is essential in decision-making for the current and future public health pandemics.


Subject(s)
Coronavirus Infections/transmission , Disease Transmission, Infectious/statistics & numerical data , Inhalation Exposure/statistics & numerical data , Pneumonia, Viral/transmission , COVID-19 , Coronavirus Infections/epidemiology , Disease Transmission, Infectious/classification , Disease Transmission, Infectious/prevention & control , Humans , Inhalation Exposure/prevention & control , Masks/statistics & numerical data , Pandemics , Pneumonia, Viral/epidemiology , Primary Prevention/methods , Primary Prevention/statistics & numerical data , Quarantine/methods , Quarantine/statistics & numerical data , Respiratory Protective Devices/statistics & numerical data , United States
SELECTION OF CITATIONS
SEARCH DETAIL